Users describe months of fatigue and twitching after unapproved peptides, as an RFK Jr. backed push could let sellers drop the research use only warning.
Recap by typeshit. Full story at Yahoo.
A local TV health segment on safety when using peptide therapy and GLP-1 drugs, aimed at men's health.
A Williamsburg shop sells injectable peptide vials for around $95 each, while the FDA has sent warning letters to sellers relying on the same label.
9:07
The endocrinologist takes on whether people can get retatrutide now, setting gray market supply against the results from Lilly's actual trials.
UW Medicine notes that many of these experimental peptides have not been regulated by the FDA, and some have never been tested in people.
A quick clip from Dr Nadolsky with a single recommendation for people on GLP-1 drugs. The habit itself isn't named in the caption.
A weightlifter describes months of fatigue and twitching after BPC-157, while FDA advisers appointed under RFK Jr. voted to ease limits on six unapproved peptides.
Loading…